"We welcome the Medicare GLP-1 Bridge as an important step in getting Wegovy to more patients and will continue to work with CMS, healthcare professionals, pharmacists, and patient advocates to support implementation and help eligible seniors access the care they need and deserve." The Medicare GLP-1 Bridge provides eligible patients access to Wegovy for weight management
Glucagon-like peptide-1 receptor agonists (GLP1-RAs), used to treat T2D and obesity, stimulate glucose-depending insulin secretion, suppress glucagon secretion and delay gastric emptying [2]
The FDA label advises considering alternative therapies in patients with a history of pancreatitis
Im also tending to reject more of the fast foods. Instead, she buys smaller portions and more fresh foodsoften shopping daily rather than in bulk
This is typically done on the same day each week to make it easier to remember
Though out of the spotlight, millions of people living with obesity have been the subject of similar comments throughout their lives